METABOLISM OF DEPRENYL, A SELECTIVE MONOAMINE-OXIDASE (MAO) B-INHIBITOR IN RAT - RELATIONSHIP OF METABOLISM TO MAO-B INHIBITORY POTENCY

被引：104

作者：

YOSHIDA, T ^{[1
]}

YAMADA, Y ^{[1
]}

YAMAMOTO, T ^{[1
]}

KUROIWA, Y ^{[1
]}

机构：

[1] SHOWA UNIV,SCH PHARMACEUT SCI,DEPT PHARMACOL,TOKYO 142,JAPAN

来源：

XENOBIOTICA | 1986年 / 16卷 / 02期

关键词：

D O I：

10.3109/00498258609043515

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：129 / 136

页数：8

共 19 条

[1]

ANGGARD E, 1977, HDB EXPT PHARM DRUG, V45, P3

[2]

BECKETT A H, 1971, Xenobiotica, V1, P365

[3]

BIRKMAYER W, 1977, LANCET, V1, P439

[4] MONOAMINE OXIDASE-B INHIBITOR DEPRENYL POTENTIATES PHENYLETHYLAMINE BEHAVIOR IN RATS WITHOUT INHIBITION OF CATECHOLAMINE METABOLITE FORMATION [J].

BRAESTRUP, C ;

ANDERSEN, H ;

RANDRUP, A .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1975, 34 (01) :181-187

[5] METABOLISM OF AMPHETAMINES IN MAMMALS [J].

CALDWELL, J .

DRUG METABOLISM REVIEWS, 1976, 5 (02) :219-280

[6] PATHWAYS OF METABOLISM OF AMPHETAMINE AND RELATED COMPOUNDS [J].

CHO, AK ;

WRIGHT, J .

LIFE SCIENCES, 1978, 22 (05) :363-371

[7] EXPERIENCES WITH L-DEPRENYL IN PARKINSONISM [J].

CSANDA, E ;

ANTAL, J ;

ANTONY, M ;

CSANAKY, A .

JOURNAL OF NEURAL TRANSMISSION, 1978, 43 (3-4) :263-269

[8] METABOLISM OF (-) DEPRENYL TO AMPHETAMINE AND METHAMPHETAMINE MAY BE RESPONSIBLE FOR DEPRENYL THERAPEUTIC BENEFIT - A BIOCHEMICAL ASSESSMENT [J].

KAROUM, F ;

CHUANG, LW ;

EISLER, T ;

CALNE, DB ;

LIEBOWITZ, MR ;

QUITKIN, FM ;

KLEIN, DF ;

WYATT, RJ .

NEUROLOGY, 1982, 32 (05) :503-509

[9]

KNOLL J, 1965, ARCH INT PHARMACOD T, V155, P154

[10] POSSIBLE MECHANISMS OF ACTION OF (-)DEPRENYL IN PARKINSONS-DISEASE [J].

KNOLL, J .

JOURNAL OF NEURAL TRANSMISSION, 1978, 43 (3-4) :177-198

← 1 2 →